Loraz and Cholestyramine light drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Loraz (lorazepam) and Cholestyramine light (cholestyramine). Common drug interactions include fibromyalgia among females and cytokine release syndrome among males.

The phase IV clinical study analyzes what interactions people have when they take Loraz and Cholestyramine light. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Loraz?

Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,694 Loraz users. Check the latest studies of Loraz.

What is Cholestyramine light?

Cholestyramine light has active ingredients of cholestyramine. It is often used in high blood cholesterol. eHealthMe is studying from 297 Cholestyramine light users. Check the latest studies of Cholestyramine light.

On Jul, 10, 2026

21 people who take Loraz and Cholestyramine light together, and have interactions are studied.

Loraz and Cholestyramine light drug interactions.

What are the common drug interactions of Loraz and Cholestyramine Light, by gender? *:

female:

Fibromyalgia (a long-term condition which causes pain all over the body)
Urinary tract infection
Abdominal mass (localized enlargement or swelling in the human abdomen)
Arthralgia (joint pain)
Colitis (inflammation of colon)
Costochondritis (chest wall pain)
Cystitis (inflammation of the wall of the bladder)
Dyspnoea (difficult or laboured respiration)
Lumbar spinal stenosis (a medical condition in which the spinal canal narrows and compresses the spinal cord and nerves at the level of the lumbar bone)
Major depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings)

male:

Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Confusional state
Blood potassium decreased
Cystitis (inflammation of the wall of the bladder)
Decreased appetite
Diarrhoea
Dysphonia (speech disorder attributable to a disorder of phonation)
Fatigue (feeling of tiredness)
Fungal infection
Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)

What are the common drug interactions of Loraz and Cholestyramine Light, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Colitis (inflammation of colon)
Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)
Blood potassium decreased
Death
Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
Oral infection
Pyrexia (fever)
Respiratory tract infection

60+:

Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Confusional state
Pain
Polyuria (production of too much dilute urine)
Spinal pain (pain in spine)
Abdominal pain
Cataract (clouding of the lens inside the eye)
Cystitis (inflammation of the wall of the bladder)
Diarrhoea
Drug ineffective

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 9 people, 42.86%
Pain: 7 people, 33.33%
Insomnia (sleeplessness): 6 people, 28.57%
Diarrhea: 5 people, 23.81%
Hypokalemia (low potassium): 4 people, 19.05%
Jock Itch (fungal infection of the groin and upper thighs): 4 people, 19.05%
Joint Pain: 4 people, 19.05%
Confusional State: 4 people, 19.05%
Neuropathy Peripheral (surface nerve damage): 4 people, 19.05%
Pneumonia: 4 people, 19.05%

* Approximation only. Some reports may have incomplete information.

Do you take Loraz and Cholestyramine light?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously